A couple of older studies found that supplementation did not improve exercise performance in adolescent males or healthy men without anemia (11)
In rodent models, reported effects in tendon, ligament, muscle and gastrointestinal tissue have been attributed to modulation of the VEGFR2 / nitric oxide pathway, upregulation of growth-hormone receptor expression in fibroblasts, and effects on FAKpaxillin signalling that influence cell migration
Earlier studies indicate that abnormal activation of the HGF/c-MET signaling pathway may hinder T-cell activation and growth, adversely affect DCs, and enhance the infiltration of immunosuppressive cells (M2-type TAMs, MDSCs, and Tregs), leading to reduced effectiveness of ICIs
Cognitive Enhancement Research Dihexa Dihexa has been directly tested in cognitive paradigms (aged rat water maze, scopolamine reversal) and demonstrates synaptogenesis through HGF/c-Met signaling, providing a more direct cognitive enhancement rationale than PE-22-28 Neurogenesis and Mood Research PE-22-28 PE-22-28 induces hippocampal neurogenesis within 4 days and demonstrates antidepressant-like effects through TREK-1 blockade, making it more relevant for mood-cognition intersection research Oral Bioavailability Requirement Dihexa Dihexa has demonstrated approximately 38% oral bioavailability with BBB penetration, while PE-22-28 oral availability has not been characterized Lower Theoretical Risk Profile PE-22-28 PE-22-28 targets an ion channel without known oncological associations, whereas Dihexa activates the HGF/c-Met pathway which is a characterized oncogenic signaling axis Evidence Reliability PE-22-28 PE-22-28 has no retracted publications in its evidence base, while a key 2014 Dihexa paper was retracted for data fabrication concerns Continue Your Research Get comparison updates We publish new head-to-head comparisons regularly
